Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Non-Hodgkin × Bortezomib × 30 days × Clear all

Sponsor

Conditions

Multiple Myeloma 26 Immunoglobulin Light-chain Amyloidosis 5 Paraproteinemias 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplasms, Plasma Cell 2 Neoplasms 2 Lymphoproliferative Disorders 2 beta-Thalassemia 1 Waldenstrom Macroglobulinemia 1 Thalassemia 1 Renal Insufficiency 1 Recurrence 1 Multi-centric Castleman's Disease 1 Macular dystrophy, corneal type 1 1 Lymphoma, Mantle-Cell 1 Lymphoma, B-Cell 1 Lymphadenopathy 1 Leukemia, Myeloid, Acute 1 Immunoproliferative Disorders 1 Hematologic Neoplasms 1 HIV Infections 1 Burkitt Lymphoma 1 Anemia, Sickle Cell 1 Amyloidosis 1

Interventions

Cyclophosphamide 14 Rituximab 12 fludarabine 11 obinutuzumab 8 fludarabine phosphate 6 tocilizumab 5 ibrutinib 5 Prednisone 5 Lenalidomide 5 glofitamab 4 Specimen Handling 4 Doxorubicin 4 Biopsy 4 polatuzumab vedotin 3 pirtobrutinib 3 X-Rays 3 Vincristine 3 Phantoms, Imaging 3 Mycophenolic Acid 3 Magnetic Resonance Spectroscopy 3 venetoclax 2 acalabrutinib 2 Whole-Body Irradiation 2 Thiotepa 2 Tacrolimus 2 Oxaliplatin 2 Nuclear Medicine Department, Hospital 2 Leukapheresis 2 Granulocyte Colony-Stimulating Factor 2 Gemcitabine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡